Insider Transactions in Q3 2022 at Sierra Oncology, Inc. (SRRA)

Date	Insider	Transaction	Ownership Type	Shares Traded	Value / Price
Jul 01 2022	Stephen George Dilly CEO and President	SELL Sale (or disposition) back to the issuer	Direct	5,000 -100.0%	$275,000 $55.0 P/Share
Jul 01 2022	Craig A Collard Director	SELL Sale (or disposition) back to the issuer	Direct	13,500 -100.0%	$742,500 $55.0 P/Share
Jul 01 2022	Andrew R Allen Director	SELL Sale (or disposition) back to the issuer	Direct	1,650 -100.0%	$90,750 $55.0 P/Share

Jul 01 2022	Barbara Klencke Chief Medical Officer	SELL Sale (or disposition) back to the issuer	Indirect	5,000 -100.0%	$275,000 $55.0 P/Share
Jul 01 2022	Barbara Klencke Chief Medical Officer	SELL Sale (or disposition) back to the issuer	Direct	10,000 -100.0%	$550,000 $55.0 P/Share
Jul 01 2022	Andrew Sinclair Director	SELL Sale (or disposition) back to the issuer	Indirect	1,314,127 -100.0%	$72,276,985 $55.0 P/Share
Jul 01 2022	Gaurav Aggarwal Director	SELL Sale (or disposition) back to the issuer	Indirect	2,735,853 -100.0%	$150,471,915 $55.0 P/Share
Jul 01 2022	Mona Ashiya Director	SELL Sale (or disposition) back to the issuer	Indirect	1,964,770 -100.0%	$108,062,350 $55.0 P/Share
Jul 01 2022	Vivo Opportunity, LLC Director	SELL Sale (or disposition) back to the issuer	Indirect	3,329,512 -100.0%	$183,123,160 $55.0 P/Share
Jul 01 2022	Orbimed Advisors LLC Director	SELL Sale (or disposition) back to the issuer	Indirect	1,964,770 -100.0%	$108,062,350 $55.0 P/Share

Receive a notification when an Institution or Guru buys or sells SRRA shares.

Notify only if

Value

Get notified when an Sierra Oncology, Inc. insider buys or sells SRRA shares.

Notify only if

Operation

Value

Type

Receive news related to Sierra Oncology, Inc.